| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
52,775,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,247,701 |
Avg
Vol: |
599,363 |
| 52
Week Range: |
$10.49 - $10.49 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2011-11-07 |
4 |
D |
$10.50 |
$4,444,041 |
D/D |
(423,242) |
0 |
|
- |
|
| Mcaree Peter F |
Sr.VP and CFO |
• – – |
2011-11-07 |
4 |
D |
$10.50 |
$659,253 |
D/D |
(62,786) |
0 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2011-11-07 |
4 |
D |
$10.50 |
$8,680,613 |
D/D |
(826,725) |
0 |
|
- |
|
| Kruka William C. |
Sr VP Corporate Development |
• – – |
2011-11-07 |
4 |
D |
$10.50 |
$863,520 |
D/D |
(82,240) |
0 |
|
- |
|
| Griffith Joseph H. Iv |
VP, Finance & Controller |
• – – |
2011-11-07 |
4 |
D |
$10.50 |
$349,514 |
D/D |
(33,287) |
0 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2011-11-07 |
4 |
D |
$10.50 |
$461,507 |
D/D |
(43,953) |
0 |
|
- |
|
| Comstock Allan L |
Director |
– • – |
2011-11-07 |
4 |
D |
$10.50 |
$274,124 |
D/D |
(26,107) |
0 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2011-11-07 |
4 |
D |
$10.50 |
$400,817 |
I/I |
(38,173) |
0 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2011-11-07 |
4 |
D |
$10.50 |
$1,938,185 |
D/D |
(184,589) |
0 |
|
- |
|
| Billet Van |
Director |
– • – |
2011-11-07 |
4 |
D |
$10.50 |
$263,624 |
D/D |
(25,107) |
0 |
|
- |
|
| Bishop Robert C |
Director |
– • – |
2011-11-07 |
4 |
D |
$10.50 |
$281,547 |
D/D |
(26,814) |
0 |
|
- |
|
| Bal Bruce J |
Sr.VP, Operations |
• – – |
2011-11-07 |
4 |
D |
$10.50 |
$1,325,930 |
D/D |
(126,279) |
0 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2011-11-01 |
4 |
AS |
$10.47 |
$52,345 |
D/D |
(5,000) |
43,953 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2011-10-31 |
4 |
OE |
$1.30 |
$928,250 |
D/D |
179,407 |
684,818 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2011-09-01 |
4 |
AS |
$7.52 |
$37,602 |
D/D |
(5,000) |
51,104 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2011-08-09 |
4 |
OE |
$6.79 |
$16,785 |
D/D |
2,472 |
647,318 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2011-08-01 |
4 |
OE |
$6.79 |
$204,834 |
I/I |
30,167 |
14,746 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2011-08-01 |
4 |
OE |
$6.79 |
$117,949 |
D/D |
17,371 |
184,589 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2011-08-01 |
4 |
AS |
$8.20 |
$41,007 |
D/D |
(5,000) |
56,104 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2011-07-15 |
4 |
OE |
$6.79 |
$54,361 |
I/I |
8,006 |
8,006 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2011-07-15 |
4 |
OE |
$6.79 |
$177,572 |
D/D |
26,152 |
167,218 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2011-07-12 |
4 |
OE |
$6.79 |
$7,347 |
D/D |
1,082 |
141,066 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2011-07-11 |
4 |
OE |
$6.29 |
$17,519 |
D/D |
2,787 |
139,984 |
|
- |
|
| Griffith Joseph H. Iv |
VP, Finance & Controller |
• – – |
2011-07-01 |
4 |
D |
$8.12 |
$3,224 |
D/D |
(397) |
33,287 |
|
- |
|
| Creager Stephen E |
Sr. VP and General Counsel |
• – – |
2011-07-01 |
4 |
AS |
$8.11 |
$40,544 |
D/D |
(5,000) |
61,104 |
|
- |
|
291 Records found
|
|
Page 1 of 12 |
|
|
